"ICER Set to Review AMX0035…"

Welcome to Connecting ALS. This week we discuss a cost-effectiveness review of AMX0035 by ICER and criticisms of the organization’s methodology that has been called discriminatory toward people with disabilities.

This week, Jeremy welcomes Dr. Neil Thakur, chief mission officer at The ALS Association, and Sara van Geertruyden, executive director at the Partnership to Improve Patient Care, to discuss a cost-effectiveness review of AMX0035 by ICER and criticisms of the organization’s methodology that has been called discriminatory toward people with disabilities.
 
For more information on the ICER review process to go als.org/icer

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.
Brought to you by The ALS Association. © 2021 The ALS Association